US Patent Issued to King's College London on June 2 for "Proinsulin peptides for Type 1 Diabetes" (British Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,934, issued on June 2, was assigned to King's College London (Greater London, Great Britain).

"Proinsulin peptides for Type 1 Diabetes" was invented by Mark Peakman (Greater London, Great Britain), Johan Verhagen (Greater London, Great Britain) and Martin Eichmann (Greater London, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is a peptide that can be used in the therapy or prevention of Type 1 Diabetes (T1D), particularly in a patient with a DR3-DQ2 haplotype, as well as methods of diagnosing or determining treatment efficacy, methods of identifying T1D-relevant antigen drivers, and to methods of identifying subjects a...